SHE:001367 Revenue

Zhejiang Haisen Pharmaceutical had revenue of 116.78M CNY in the quarter ending September 30, 2025, with 6.74% growth. This brings the company's revenue in the last twelve months to 510.33M, up 17.50% year-over-year. In the year 2024, Zhejiang Haisen Pharmaceutical had annual revenue of 471.51M with 18.63% growth.

Revenue (ttm)

510.33M

Revenue Growth

+17.50%

P/S Ratio

6.78

Revenue / Employee

769.73K

Employees

663

Market Cap

3.46B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	471.51M	74.06M	18.63%
Dec 31, 2023	397.45M	-25.32M	-5.99%
Jan 1, 2023	422.78M	33.79M	8.69%
Dec 31, 2021	388.98M	104.18M	36.58%
Dec 31, 2020	284.80M	18.47M	6.94%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Shenqi Pharmaceutical Investment Management	1.88B
Guangdong Jiaying Pharmaceutical	410.00M
Zhejiang Zhenyuan Share	2.67B
Hubei Guangji Pharmaceutical	605.87M
Shandong Keyuan Pharmaceutical	435.52M
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd	251.56M
Hangzhou Bio-Sincerity Pharma-Tech	590.33M
Hangzhou Minsheng Healthcare	744.06M

Revenue Rankings